Mankind Pharma Q1 results: Profit rises 10% to ₹543 cr; revenue up 12%
The revenue from domestic business grew 9% YoY to ₹2,634 cr in Q1 FY25, while exports rose 62% YoY to ₹259 cr
prega news
July 2024
November 2023
August 2023
April 2023
Mankind Pharma shares drop 3% post Q2
Mankind Pharma has reported 19.4% YoY rise in profit at ₹501.03 cr in Q2 FY24, while revenue from operations jumped 11.6% to ₹2,708.10 cr.
Mankind Pharma shares jump 10% on robust Q1; up 77% against IPO price
The pharma major reported 66% YoY growth in net profit at ₹494 crore, while sales rose 18% YoY to ₹2,579 crore in Q1FY24.
Despite muted response from retail investors, Mankind Pharma IPO subscribed 15 times
The portion reserved for QIBs was subscribed over 49 times, while quota for NIIs and retail investors were booked 3.8% times and 0.9 times, respectively.
Mankind Pharma to launch IPO this month; looks to raise around ₹4,700 cr
The IPO of the country’s fourth largest pharma company by domestic sales comprises an offer for the sale of 4 crore equity shares by the promoters and existing investors.
